Low risk of SARS-CoV-2 in blood transfusion.

Michael OwusuAugustina Angelina AnnanPhilip El-DuahNana Kwame Ayisi-BoatengRichmond YeboahEric AduJesse AsamoahMichael FrimpongJaphet Senyo Kamasah Godfred AcheampongMohamed MutocheluhJohn AmuasiEllis Owusu-DaboYaw Adu-SarkodieRichard Odame Phillips

Published in: PloS one (2021)

This study reports the identification of SARS-CoV-2 viral RNA in a convalescent individual in Ghana. Due to the low prevalence observed and the marginal cycling thresholds associated, the risk of transfusion transmission of SARS-CoV-2 is negligible. Well-powered studies and advanced diagnostics to determine infectious viremia is recommended to further evaluate the potential risk of hematogenous transmission among recovered patients.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
risk factors
prognostic factors
emergency department
cardiac surgery
high intensity
coronavirus disease
adverse drug
drug induced